![Michael Biega](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Biega
Investor Relations Contact bij
HARROW, INC.
Profiel
Michael Biega is currently VP-Investor Relations & Communications at Harrow, Inc. since 2025.
Formerly, Mr. Biega was Managing Director at Solebury Strategic Communications LLC and Senior Director-Investor Relations at Sensei Biotherapeutics, Inc.
Actieve functies van Michael Biega
| Bedrijven | Functie | Begin |
|---|---|---|
| HARROW, INC. | Investor Relations Contact | 18-06-2025 |
Eerdere bekende functies van Michael Biega
| Bedrijven | Functie | Einde |
|---|---|---|
Solebury Strategic Communications LLC
 Solebury Strategic Communications LLC Miscellaneous Commercial ServicesCommercial Services Provides investor relations and corporate communications services | Corporate Officer/Principal | - |
| FAETH THERAPEUTICS, INC. | Investor Relations Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
2
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Harrow, Inc.
 Harrow, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development, production, and sale of innovative medications | Health Technology |
Solebury Strategic Communications LLC
Solebury Strategic Communications LLC Miscellaneous Commercial ServicesCommercial Services Provides investor relations and corporate communications services | Commercial Services |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
